MD4054B1 - Method for determining the capacity of altered albumin ischemic binding of cobalt - Google Patents
Method for determining the capacity of altered albumin ischemic binding of cobaltInfo
- Publication number
- MD4054B1 MD4054B1 MDA20090116A MD20090116A MD4054B1 MD 4054 B1 MD4054 B1 MD 4054B1 MD A20090116 A MDA20090116 A MD A20090116A MD 20090116 A MD20090116 A MD 20090116A MD 4054 B1 MD4054 B1 MD 4054B1
- Authority
- MD
- Moldova
- Prior art keywords
- ischemic
- determining
- cobalt
- binding
- albumin
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Inventia se refera la medicina, in particular lao metoda de determinare a capacitati albuminei ischemic modificate de legare a cobaltului si poate fi folosita pentru diagnosticarea proceselor patologice cauzate de hipoxia tesuturilor si organelor, cercetarea patogenezei acestora si stabilirea metodelor de tratament. Metoda, conform inventiei, include prelucrarea materialului biologic cu solutie de 0,50...0,75 mM de clorura de cobalt, agitarea timp de 5 min la temperatura camerei, adaugarea unui mediu de incubare, ce contine, mM: ditiotreitol 10,0...20,0, solutie tampon HEPES pH 7,4 10,0...25,0, clorura de sodiu 140,0...150,0 si heptanol 0,3...1,0, agitarea timp de 2 min, masurarea densitatii optice a complexului obtinut la o lungime de unda de 485 nm si determinarea capacitatii albuminei ischemic modificate de legare a cobaltului.The invention relates to medicine, in particular to the method of determining the ischemic albumin capacity modified by cobalt binding and can be used to diagnose pathological processes caused by hypoxia of tissues and organs, to investigate their pathogenesis and to establish treatment methods. The method according to the invention includes the processing of biological material with 0.50 to 0.75 mM solution of cobalt chloride, stirring for 5 min at room temperature, adding an incubation medium containing, mM: dithiothreitol 10, 0 ... 20.0, HEPES buffer solution pH 7.4 10.0 ... 25.0, sodium chloride 140.0 ... 150.0 and heptanol 0.3 ... 1.0, stirring for 2 min, measuring the optical density of the complex obtained at a wavelength of 485 nm and determining the ability of altered ischemic albumin for cobalt binding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20090116A MD4054C1 (en) | 2009-11-06 | 2009-11-06 | Method for determining the cobalt binding ability of the ischemic modified albumin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20090116A MD4054C1 (en) | 2009-11-06 | 2009-11-06 | Method for determining the cobalt binding ability of the ischemic modified albumin |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4054B1 true MD4054B1 (en) | 2010-07-30 |
MD4054C1 MD4054C1 (en) | 2011-02-28 |
Family
ID=43569012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20090116A MD4054C1 (en) | 2009-11-06 | 2009-11-06 | Method for determining the cobalt binding ability of the ischemic modified albumin |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4054C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102507916B (en) * | 2011-11-07 | 2013-11-06 | 宁波美康生物科技股份有限公司 | Ischemia modified albumin liquid stabilization kit |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATA194989A (en) * | 1989-08-17 | 1990-04-15 | Koller Ernst | METHOD FOR DETECTING AND DETERMINING HUMAN SERUM ALBUMINE IN BIOLOGICAL LIQUIDS WITH THE AID OF FLUOROGENIC CYANINE DYES |
SU1677632A1 (en) * | 1989-09-10 | 1991-09-15 | Азербайджанский Государственный Медицинский Институт Им.Н.Нариманова | Method for examination of cardiovascular system |
SU1720004A1 (en) * | 1990-01-18 | 1992-03-15 | Научно-Исследовательский Институт Физико-Химической Медицины Мз Рсфср | Method for determining albumin-globulin blood coefficient |
RU2102756C1 (en) * | 1995-05-22 | 1998-01-20 | Сибирский медицинский университет | Method of prognosis of ischemic heart disease course |
RU2182709C2 (en) * | 2000-04-28 | 2002-05-20 | Уральский НИИ охраны материнства и младенчества МЗ РФ | Method or preclinical diagnosis of hepatodepressive syndrome in gestation |
MD3394G2 (en) * | 2007-01-09 | 2008-04-30 | Диомид ГЕРМАН | Method of spinal marrow infarction diagnosis |
-
2009
- 2009-11-06 MD MDA20090116A patent/MD4054C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD4054C1 (en) | 2011-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Suresh et al. | Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension | |
ATE503000T1 (en) | DEVICE, SYSTEM AND METHOD FOR OBSERVING AND/OR CULTIVING MICROSCOPIC OBJECTS | |
ES2571135T3 (en) | Glucose Sensor Calibration Method | |
EP2583053A4 (en) | Differential interference contrast serial time encoded amplified microscopy | |
FR2928919B1 (en) | PROCESS FOR THE PREPARATION OF DIFLUOROACETIC ACID AND ITS SALTS | |
MD4054B1 (en) | Method for determining the capacity of altered albumin ischemic binding of cobalt | |
Hu et al. | Biomass-based quantum dots co-doped with sulfur and nitrogen for highly sensitive detection of thrombin and its inhibitor | |
CN105548097B (en) | A kind of competent cell imaging method using fluorescence probe under extreme ph values | |
RU2007144412A (en) | METHOD FOR DETERMINING ANTITROMBOTIC EFFECT OF ACETYL SALICYLIC ACID | |
Zhang et al. | Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes | |
FR2948381B1 (en) | PROCESS FOR OBTAINING MYOFIBROBLASTS | |
WO2009046820A3 (en) | Transparent cooling gel | |
ES2570609T3 (en) | Method for testing aminoacylase 1 for in vitro diagnosis of colorectal cancer | |
ATE473437T1 (en) | GROWING, FREEZING AND TESTING CULTURED CELLS IN SITU | |
Tsukamoto | Autophagic activity as an indicator for selecting good quality embryos | |
JP2002122568A (en) | Method and apparatus for noninvasive quality evaluation of mammal embryo | |
AR073494A1 (en) | STABLE CELL CLONE EXPRESSING A PRION | |
Lunardi et al. | Overexpression of hypoxia-inducible factor-1α in primary graft dysfunction developing in an orthotopic lung transplantation rat model | |
FR2923391B1 (en) | COMPOSITIONS FOR PRESERVING CELLS, TISSUES OR ORGANS, METHOD OF OBTAINING AND USES. | |
Blazeski et al. | Engineering microvascular networks using a KLF2 reporter to probe flow-dependent endothelial cell function | |
CN203017190U (en) | Medical dry film or medical wet film with fluid leaking seam | |
Sciorio et al. | Exploring the effect of cryopreservation in assisted reproductive technology and potential epigenetic risk | |
PL425131A1 (en) | polyRGD peptides obtained by chemical and biotechnological method with antidemarcation and/or neuroprotective effect and a set for determination of their activity | |
MA32307B1 (en) | The process of determining the rate of hemoglobin and numbering and distinguishing white blood cells in an appropriate environment | |
CN107849531A (en) | serum-free cell culture medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) |